 phase liposom mtp-pe-activ autolog monocyt patient periton carcinomatosi phase autolog monocyt ex vivo patient periton carcinomatosi blood monocyt leukapheresi counterflow elutri cell puriti Ex vivo activ cell microgram liposom monocyt hour hydrophob cultur bag degre carbon dioxid air activ monocyt periton caviti week consecut week implant periton infus system port-a-cath pharmacia deltec St paul MN intrapati dose-escal schedul monocyt sever advers reaction toxic mild chief acut reaction fever chill abdomin pain none side effect reduct consist chang hemostat function liver function renal function signific increas granulocyt count neopterin acut phase reactant fibrinogen c-reactiv protein peripher blood vitro monocyt activ relaps procoagul activ monokin tumor necrosi factor-alpha tnf supernat cultur monocyt evid vivo monocyt activ increas monokin periton fluid kinet studi autolog monocyt patient monocyt periton caviti day locoregion immunotherapeut approach view adjuv therapeut modal ovarian cancer patient minim residu intraabdomin diseas second-look laparotomi